[HTML][HTML] Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma
D Hose, T Rème, T Hielscher, J Moreaux… - …, 2011 - ncbi.nlm.nih.gov
Haematologica, 2011•ncbi.nlm.nih.gov
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted
treatment in multiple myeloma - PMC Back to Top Skip to main content NIH NLM Logo Access
keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC
Full-Text Archive Search in PMC Advanced Search User Guide Journal List Haematologica
v.96(1); 2011 Jan PMC3012769 Other Formats PDF (709K) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases …
treatment in multiple myeloma - PMC Back to Top Skip to main content NIH NLM Logo Access
keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC
Full-Text Archive Search in PMC Advanced Search User Guide Journal List Haematologica
v.96(1); 2011 Jan PMC3012769 Other Formats PDF (709K) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases …
Abstract
Background
Proliferation of malignant plasma cells is a strong adverse prognostic factor in multiple myeloma and simultaneously targetable by available (eg tubulin polymerase inhibitors) and upcoming (eg aurora kinase inhibitors) compounds.
ncbi.nlm.nih.gov